Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Allogene Therapeutics (ALLO) Interest Coverage Ratio (2024 - 2025)

Allogene Therapeutics' Interest Coverage Ratio history spans 2 years, with the latest figure at 130.53 for Q3 2025.

  • For Q3 2025, Interest Coverage Ratio rose 81.81% year-over-year to 130.53; the TTM value through Sep 2025 reached 269.75, up 90.94%, while the annual FY2024 figure was 1509.39, N/A changed from the prior year.
  • Interest Coverage Ratio for Q3 2025 was 130.53 at Allogene Therapeutics, up from 212.01 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 130.53 in Q3 2025 and bottomed at 746.79 in Q4 2024.